The widely used medication for type 2 diabetes treatment, glucagon-like peptide-1 (GLP-1) receptor agonist, is being linked to blood clots and DVT
Oxidative-stress related gene polymorphism in endometriosis-associated infertility
This guides whether to stay with semaglutide, switch to tirzepatide, or use a dual compound, potentially cutting months of trial-and-error off your treatment timeline
100% Unscented: No essential oils or synthetic fragrancesjust the pure, clean aroma of natural ingredients
Pros: One of the most extensively studied healing peptides in animal and in vitro models, with a broad published mechanistic literature Reported to have a favorable short-term tolerability profile in the limited human data available, with side effects typically mild and self-limiting Available in both injectable and oral research formulations, offering flexibility for different use cases Cons: No completed Phase 2 or Phase 3 human clinical trials exist
In developing countries, B12 deficiency is much higher